Agmatine - A novel endogenous ligand of imidazoline receptors

Polish Journal of Pharmacology

Volumn 49, Issue 2-3, 1997, Pages 85-88

  Herman, Zbigniew S ^a  

^a UNIVERSITY OF SILESIA   (Poland)

Author keywords

Agmatine; Endogenous ligand; Imidazoline receptors

Indexed keywords

AGMATINE; ALPHA 2 ADRENERGIC RECEPTOR; AMINE OXIDASE (COPPER CONTAINING); ARGININE DECARBOXYLASE; BRADYKININ; CLONIDINE DISPLACING SUBSTANCE; ENZYME INHIBITOR; GLYCERYL TRINITRATE; GUANIDINE DERIVATIVE; IMIDAZOLINE RECEPTOR; ISOPRENALINE; LIGAND; MORPHINE; MOXONIDINE; NITRIC OXIDE; OPIATE RECEPTOR; PHENELZINE; RILMENIDINE;

BIOSYNTHESIS; BRAIN; CARDIOVASCULAR FUNCTION; LIGAND BINDING; METABOLISM; NEUROMODULATION; NONHUMAN; RECEPTOR BINDING; SHORT SURVEY; TISSUE DISTRIBUTION;

AGMATINE; ANIMALS; LIGANDS; RECEPTORS, DRUG;

EID: 0030786407     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (24)

1. Atlas D.: Molecular and physiological properties of clonidine-displacing substance. Ann. N. Y. Acad. Sci., 1995, 763, 314-324.
2. Berden D., Puech R., Loubatieres-Mariani M.-M., Bertrand G.: Agmatine is not a good candidate as endogenous ligand for imidazoline sites of pancreatic B cells and vascular bed. Eur. J. Pharmacol., 1996, 308, 301-304.
3. Chan C. K. S., Sannajust F., Head G. A.: Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits. J. Pharmacol. Exp. Ther., 1996, 276, 411-420.
4. 1-imidazoline sites. J. Pharmacol. Exp. Ther., 1993, 264, 172-182.
5. 2-adrenoceptors in the ventralateral medulla. Eur. J. Pharmacol., 1987, 134, 1-13.
6. Gao Y., Gumusel B., Koves G., Prasad A., Hao Q., Hyman A., Lippton H.: Agmatine: a novel endogenous vasodilator substance. Life Sci., 1995, 57, PL83-86.
7. Hieble J. P., Ruffola R. R. Jr.: Possible structural and functional relationship between imidazoline receptors and alpha2-adrenoceptors. Ann. N. Y. Acad. Sci., 1955, 763, 8-21.
8. Holt A., Baker G. B.: Metabolism of agmatine (clonidine-displacing substance) by diamine oxidase and the possible implications for studies of imidazoline receptors. Prog. Brain Res., 1995, 106, 187-197.
9. Ishikawa T., Misonou T., Ikeno M., Sato K., Sakamaki T.: N omega hydroxyagmatine: a novel substance causing endothelium-dependent vasorelaxations. Biochem. Biophys. Res. Commun., 1995, 214, 145-151.
10. Ivkovic B., Bakthavachalam V., Zhang W., Parini A., Diz D., Bosch S., Neumeyer J. L., Lanier S. M.: Development of a high-affinity radioiodinated ligand for identification of imidazoline/guanidinium receptive sites (IGRS): intratissue distribution of IGRS in liver, forebrain and kidney. Mol. Pharmacol., 1994, 46, 15-23.
11. Kalra S. P., Pearson E., Sahu A., Kalra P. S : Agmatine, a novel hypothalamic amine, stimulates pituitary luteinizing hormone release in vivo and hypothalamic luteinizing hormone-releasing hormone release in vitro. Neurosci. Lett., 1995, 194, 165-168.
12. Kolesnikov Y., Jain S., Pasternak G. W.: Modulation of opioid analgesia by agmatine. Eur. J. Pharmacol., 1996, 296, 17-22.
13. Li G., Regunathan S., Barrow C. J., Eshraghi J., Cooper R., Reis D. J.: Agmatine is an endogenous clonidine displacing substance in brain. Science, 1994, 263, 966-969.
14. Li G., Regunathan S., Reis D. J.: Agmatine is synthesized by a mitochondrial arginine decarboxylase in rat brain. Ann. N. Y. Acad. Sci., 1995, 763, 325-329.
15. Mallard N. J., Hudson A. L., Nutt D. J.: Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain. Brit. J. Pharmacol., 1992, 106, 1019-1027.
16. Michel M. C., Ernsberger P.: Keeping and eye on the I site: imidazoline-preferring receptors. Trends Pharmacol. Sci., 1992, 13, 369-370.
17. Morrissey J., Mc Cracken R., Ishidoya S., Klahr S.: Partial cloning and characterization of an arginine decarboxylase in the kidney. Kidney Int., 1995, 47, 1458-1461.
18. Raasch W., Regunathan S., Li G., Reis D. J.: Agmatine is widely and unequally distributed in rat organs. Ann. N. Y. Acad. Sci., 1995, 763, 330-334.
19. Regunathan S., Feinstein D. L., Reis D. J.: Expression of non-adrenergic imidazoline sites in rat cerebral cortical astrocytes. J. Neurosci. Res., 1993, 34, 681-688.
20. Regunathan S., Feinstein D. L., Roasch W., Reis D. J.: Agmatine (decarboxylated arginine) is synthesized and stored in astrocytes. Neuroreport, 1995, 6, 1897-1900.
21. Regunathan S., Youngson C., Wang H., Reis D.J.: Imidazoline receptors in vascular smooth muscle and endothelial cells. Ann. N. Y. Acad. Sci., 1995, 763, 580-590.
22. Reis D. J.: Neurons and receptors in the rostroventrolateral medulla mediating the antihypertensive actions of drug acting at imidazoline receptors. J. Cardiovasc. Pharmacol., 1996, 27 Suppl. 3, S11-S18.
23. Reis D.J., Li D., Regunathan S.: Endogenous ligands of imidazoline receptors: classic and immunoreactive clonidine displacing substance and agmatine. Ann. N. Y. Acad. Sci., 1995, 736, 295-313.
24. Tesson F., Parcini A.: Identification of an imidazoline-guanidinium receptive site in mitochondria from rabbit cerebral cortex. Eur. J. Pharmacol., 1991, 208, 81-83.